Eur Rev Med Pharmacol Sci 2021; 25 (1): 127-138DOI: 10.26355/eurrev_202101_24375 Exosomes derived from Taxol-resistant nasopharyngeal carcinoma (NPC) cells transferred DDX53 to NPC cells and promoted cancer resistance to Taxol F. Yuan, Z.-F. Zhou Free PDF Download
Eur Rev Med Pharmacol Sci 2021; 25 (1): 116-126DOI: 10.26355/eurrev_202101_24355 Integrative analysis of the characteristics of lipid metabolism-related genes as prognostic prediction markers for hepatocellular carcinoma P. Zhu, F.-F. Li, J. Zeng, D.-G. Tang, W.-B. Chen, C.-C. Guo Free PDF Download
Eur Rev Med Pharmacol Sci 2021; 25 (1): 108-115DOI: 10.26355/eurrev_202101_24354 LINC00641 regulates prostate cancer cell growth and apoptosis via the miR-365a-3p/VGLL4 axis W.-H. Liu, J.-J. Lu, R.-K. Yu, L. Zhou, Q. Yu, D.-F. Li, Q.-H. Zhu Free PDF Download
Eur Rev Med Pharmacol Sci 2021; 25 (1): 94-107DOI: 10.26355/eurrev_202101_24353 Effect and mechanism of miR-217 on drug resistance, invasion and metastasis of ovarian cancer cells through a regulatory axis of CUL4B gene silencing/inhibited Wnt/β-catenin signaling pathway activation H.-R. Liu, J. Zhao Free PDF Download
Eur Rev Med Pharmacol Sci 2021; 25 (1): 86-93DOI: 10.26355/eurrev_202101_24352 Circular RNA CircMTO1 suppressed proliferation and metastasis of osteosarcoma through miR-630/KLF6 axis D.-Y. Liu, Z. Li, K. Zhang, N. Jiao, D.-G. Lu, D.-W. Zhou, Y.-B. Meng, L. Sun Free PDF Download
Eur Rev Med Pharmacol Sci 2021; 25 (1): 78-85DOI: 10.26355/eurrev_202101_24351 PPM1D accelerates proliferation and metastasis of osteosarcoma by activating PKP2 X.-L. He, Q. Xiao, Z.-P. Zhou, C.-Y. Hui Free PDF Download
Eur Rev Med Pharmacol Sci 2021; 25 (1): 14-15DOI: 10.26355/eurrev_202101_24338 Comment on “A meta-analysis of influence of MSMB promoter rs10993994 polymorphisms on prostate cancer risk” Y.-Y. Feng, H.-Y. Pan, Y.-Y. Mi, L.-J. Zhu Free PDF Download
Eur Rev Med Pharmacol Sci 2020; 24 (24): 13101-13102DOI: 10.26355/eurrev_202012_24218 Editorial – Breast cancer: awake surgery as strategy during second COVID-19 lockdown? G. Vanni, O.C. Buonomo, P. Gualtieri, G. Merra Free PDF Download
Eur Rev Med Pharmacol Sci 2020; 24 (24): 12748-12756DOI: 10.26355/eurrev_202012_24174 Long non-coding RNA NR2F1-AS1 promoted neuroblastoma progression through miR-493-5p/TRIM2 axis L. Liu, H. Zhao, H.-H. He, J. Huang, Y.-Y. Xu, X.-L. Li, Y. Wu, J. Wang, Y.-B. Zhu Free PDF Download
Eur Rev Med Pharmacol Sci 2020; 24 (24): 12741-12747DOI: 10.26355/eurrev_202012_24173 MiR-587 acts as an oncogene in non-small-cell lung carcinoma via reducing CYLD expression X.-J. Li, L.-W. Chen, P. Gao, Y.-J. Jia Free PDF Download
Eur Rev Med Pharmacol Sci 2020; 24 (24): 12735-12740DOI: 10.26355/eurrev_202012_24172 Effect of CTCs and INHBA level on the effect and prognosis of different treatment methods for patients with early breast cancer X.-Q. Wang, B. Liu, B.-Y. Li, T. Wang, D.-Q. Chen Free PDF Download
Eur Rev Med Pharmacol Sci 2020; 24 (24): 12727-12734DOI: 10.26355/eurrev_202012_24171 Use of Eribulin mesylate as second-line therapy in elderly patients with HER/2 negative metastatic breast cancer (MBC): efficacy, tolerability and Quality of Life R. De Luca, M. Alù, G. Genova, A. Grassadonia, G. Cicero Free PDF Download
Eur Rev Med Pharmacol Sci 2020; 24 (24): 12717-12726DOI: 10.26355/eurrev_202012_24170 Inhibition of miR-133b indicates poor prognosis and promotes progression of OSCC via SOX4 J. Yang, H. Wang, W. Xu, Z. Chen, Z.-Y. Yan, L.-J. Zhang Free PDF Download
Eur Rev Med Pharmacol Sci 2020; 24 (24): 12709-12716DOI: 10.26355/eurrev_202012_24169 PRKD3 promotes malignant progression of OSCC by downregulating KLF16 expression Z. Chen, Q. Huang, W. Xu, H. Wang, J. Yang, L.-J. Zhang Free PDF Download
Eur Rev Med Pharmacol Sci 2020; 24 (24): 12701-12708DOI: 10.26355/eurrev_202012_24168 Molecular insights into the development of hepatic metastases in colorectal cancer: a metastasis prediction study J. Yang, H. Kim, K. Shin, Y. Nam, H.J. Heo, G.H. Kim, B.-Y. Hwang, J. Kim, S. Woo, H.S. Choi, D.S. Ko, D. Lee, Y.H. Kim Free PDF Download
Eur Rev Med Pharmacol Sci 2020; 24 (24): 12694-12700DOI: 10.26355/eurrev_202012_24167 MiRNA-15a-3p inhibits the metastasis of hepatocellular carcinoma by interacting with HMOX1 C. Jiang, Z.-L. He, X.-H. Hu, P.-Y. Ma Free PDF Download
Eur Rev Med Pharmacol Sci 2020; 24 (24): 12686-12693DOI: 10.26355/eurrev_202012_24166 ATG4 promotes cell proliferation, migration and invasion in HCC and predicts a poor prognosis X.-J. Zhu, X. Jin, L. Dai, X. Liu, Z. Liu Free PDF Download
Eur Rev Med Pharmacol Sci 2020; 24 (24): 12675-12685DOI: 10.26355/eurrev_202012_24165 The diagnostic performance of PIVKA-II in metabolic and viral hepatocellular carcinoma: a pilot study U. Basile, L. Miele, C. Napodano, G. Ciasca, F. Gulli, K. Pocino, N. De Matthaeis, A. Liguori, A. De Magistris, G. Marrone, M. Biolato, M. Marino, F. Di Giacinto, A. Gasbarrini, A. Grieco, G.L. Rapaccini Free PDF Download
Eur Rev Med Pharmacol Sci 2020; 24 (24): 12667-12674DOI: 10.26355/eurrev_202012_24164 Long-chain non-coding RNA LINC01554 promotes NGFR expression and inhibits cell proliferation, migration, and invasion in hepatocellular carcinoma by binding to microRNA-3681-3p Q.-Y. Hao, L.-H. Gao, W.-Y. Niu, G.-J. Wang, P. Zhang, L. Chen, D.-M. Zhu, W.-B. Shao Free PDF Download
Eur Rev Med Pharmacol Sci 2020; 24 (24): 12655-12666DOI: 10.26355/eurrev_202012_24163 Mechanism of miR-122-5p regulating the activation of PI3K-Akt-mTOR signaling pathway on the cell proliferation and apoptosis of osteosarcoma cells through targeting TP53 gene K.-W. Li, S.-H. Wang, X. Wei, Y.-Z. Hou, Z.-H. Li Free PDF Download